HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD
Citação
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, v.36, article ID e1763, 4p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: Hepatosplenic schistosomiasis is an endemic disease prevalent in tropical countries and is associated with a high incidence of portal vein thrombosis. Inflammatory changes caused by both parasitic infection and portal thrombosis can lead to the development of chronic liver disease with potential carcinogenesis. AIMS: To assess the incidence of portal vein thrombosis and hepatocellular carcinoma in patients with schistosomiasis during long-term follow-up. METHODS: A retrospective study was conducted involving patients with schistosomiasis followed up at our institution between 1990 and 2021. RESULTS: A total of 126 patients with schistosomiasis were evaluated in the study. The mean follow-up time was 16 years (range 5-31). Of the total, 73 (57.9%) patients presented portal vein thrombosis during follow-up. Six (8.1%) of them were diagnosed with hepatocellular carcinoma, all with portal vein thrombosis diagnosed more than ten years before. CONCLUSIONS: The incidence of hepatocellular carcinoma in patients with schistosomiasis and chronic portal vein thrombosis highlights the importance of a systematic long-term follow-up in this group of patients.
Palavras-chave
Schistosomiasis, Portal vein, Thrombosis, Hepatocellular carcinoma
Referências
  1. AlGabbani Q, 2022, SAUDI J BIOL SCI, V29, P848, DOI 10.1016/j.sjbs.2021.10.022
  2. American College of Radiology, Liver Reporting & Data System (LIRADS
  3. Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x
  4. Calvisi DF, 2020, HEPATOLOGY, V72, P375, DOI 10.1002/hep.31392
  5. Cançado GGL, 2021, T ROY SOC TROP MED H, V115, P1004, DOI 10.1093/trstmh/trab013
  6. Coelho FF, 2014, ABCD-ARQ BRAS CIR DI, V27, P138, DOI 10.1590/S0102-67202014000200011
  7. El-Tonsy Manar Mahmoud, 2016, J Parasit Dis, V40, P976, DOI 10.1007/s12639-014-0618-0
  8. El-Tonsy MM, 2013, ACTA TROP, V128, P542, DOI 10.1016/j.actatropica.2013.07.024
  9. Ferraz Álvaro Antônio Bandeira, 2011, Rev. Col. Bras. Cir., V38, P35
  10. Ferreira FG, 2009, WORLD J SURG, V33, P2136, DOI 10.1007/s00268-009-0196-y
  11. Filgueira NA, 2018, BRAZ J INFECT DIS, V22, P352, DOI 10.1016/j.bjid.2018.06.001
  12. Guérin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125493
  13. Herman P, 2021, ABCD-ARQ BRAS CIR DI, V34, DOI 10.1590/0102-672020210002e1641
  14. Intagliata NM, 2019, GASTROENTEROLOGY, V156, P1582, DOI 10.1053/j.gastro.2019.01.265
  15. Kim T, 2004, AM J ROENTGENOL, V183, P1333, DOI 10.2214/ajr.183.5.1831333
  16. Makdissi FF, 2010, WORLD J SURG, V34, P2682, DOI 10.1007/s00268-010-0717-8
  17. Makdissi FF, 2009, ABCD-ARQ BRAS CIR DI, V22, P212, DOI 10.1590/S0102-67202009000400006
  18. Makdissi Fábio Ferrari, 2009, Arq. Gastroenterol., V46, P50, DOI 10.1590/S0004-28032009000100014
  19. Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913
  20. Martins-Melo FR, 2014, INT J PARASITOL, V44, P1055, DOI 10.1016/j.ijpara.2014.07.009
  21. Palumbo E, 2007, INFECT DIS CLIN PRAC, V15, P145, DOI 10.1097/01.idc.0000269904.90155.ce
  22. Prasad D, 2021, KAOHSIUNG J MED SCI, V37, P355, DOI 10.1002/kjm2.12368
  23. Roderfeld M, 2020, HEPATOLOGY, V72, P626, DOI 10.1002/hep.30192
  24. Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173
  25. de Freitas ACT, 2022, ABCD-ARQ BRAS CIR DI, V35, DOI 10.1590/0102-672020220002e1701
  26. Toda KS, 2015, J CLIN TRANSL HEPATO, V3, P260, DOI 10.14218/JCTH.2015.00027
  27. World Health Organization, Shistosomiasis (Bilharzia)
  28. Yosry A, 2006, CONTRIB MICROBIOL, V13, P81, DOI 10.1159/000092967